US2002128454A1PendingUtilityA1

CACNGLIKE3 polypeptides

42
Priority: Sep 8, 1998Filed: Jun 18, 2001Published: Sep 12, 2002
Est. expirySep 8, 2018(expired)· nominal 20-yr term from priority
G01N 2500/04C07K 14/705G01N 33/6872A61K 38/00
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

CACNGLIKE3 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CACNGLIKE3 polypeptides and polynucleotides in diagnostic assays.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . An isolated polypeptide selected from the group consisting of: 
 (a) an isolated polypeptide encoded by a polynucleotide comprising the sequence of SEQ ID NO:1; (b) an isolated polypeptide comprising a polypeptide sequence having at least 95% identity to the polypeptide sequence of SEQ ID NO:2;    (c) an isolated polypeptide comprising the polypeptide sequence of SEQ ID NO:2;    (d) an isolated polypeptide having at least 95% identity to the polypeptide sequence of SEQ ID NO:2;    (e) the polypeptide sequence of SEQ ID NO:2; and    (f) fragments and variants of such polypeptides in (a) to (e).    
     
     
         2 . An isolated polynucleotide selected from the group consisting of: 
 (a) an isolated polynucleotide comprising a polynucleotide sequence having at least 95% identity to the polynucleotide sequence of SEQ ID NO:1;    (b) an isolated polynucleotide comprising the polynucleotide of SEQ ID NO:1;    (c) an isolated polynucleotide having at least 95% identity to the polynucleotide of SEQ ID NO:1;    (d) the isolated polynucleotide of SEQ ID NO:1;    (e) an isolated polynucleotide comprising a polynucleotide sequence encoding a polypeptide sequence having at least 95% identity to the polypeptide sequence of SEQ ID NO:2;    (f) an isolated polynucleotide comprising a polynucleotide sequence encoding the polypeptide of SEQ ID NO:2;    (g) an isolated polynucleotide having a polynucleotide sequence encoding a polypeptide sequence having at least 95% identity to the polypeptide sequence of SEQ ID NO:2;    (h) an isolated polynucleotide encoding the polypeptide of SEQ ID NO:2;    (i) an isolated polynucleotide with a nucleotide sequence of at least 100 nucleotides obtained by screening a library under stringent hybridization conditions with a labeled probe having the sequence of SEQ ID NO: 1 or a fragment thereof having at least 15 nucleotides;    (j) a polynucleotide which is the RNA equivalent of a polynucleotide of (a) to (i);    or a polynucleotide sequence complementary to said isolated polynucleotide    and polynucleotides that are variants and fragments of the above mentioned polynucleotides or that are complementary to above mentioned polynucleotides, over the entire length thereof.    
     
     
         3 . An antibody immunospecific for the polypeptide of  claim 1 .  
     
     
         4 . An antibody as claimed in  claim 3  which is a polyclonal antibody.  
     
     
         5 . An expression vector comprising a polynucleotide capable of producing a polypeptide of  claim 1  when said expression vector is present in a compatible host cell.  
     
     
         6 . A process for producing a recombinant host cell which comprises the step of introducing an expression vector comprising a polynucleotide capable of producing a polypeptide of  claim 1  into a cell such that the host cell, under appropriate culture conditions, produces a polypeptide of  claim 1 .  
     
     
         7 . A recombinant host cell produced by the process of  claim 6 .  
     
     
         8 . A membrane of a recombinant host cell of  claim 7  expressing said polypeptide.  
     
     
         9 . A process for producing a polypeptide which comprises culturing a host cell of  claim 7  under conditions sufficient for the production of said polypeptide and recovering said polypeptide from the culture.  
     
     
         10 . An isolated polynucleotide selected form the group consisting of: 
 (a) an isolated polynucleotide comprising a nucleotide sequence which has at least 95% identity to SEQ ID NO:3 over the entire length of SEQ ID NO:3;    (b) an isolated polynucleotide comprising the polynucleotide of SEQ ID NO:3;    (c) the polynucleotide of SEQ ID NO:3; or    (d) an isolated polynucleotide comprising a nucleotide sequence encoding a polypeptide which has at least 95% identity to the amino acid sequence of SEQ ID NO:4, over the entire length of SEQ ID NO:4.    
     
     
         11 . A polypeptide selected from the group consisting of: 
 (a) a polypeptide which comprises an amino acid sequence which has at least 95% identity to that of SEQ ID NO:4 over the entire length of SEQ ID NO:4;    (b) a polypeptide in which the amino acid sequence has at least 95% identity to the amino acid sequence of SEQ ID NO:4 over the entire length of SEQ ID NO:4;    (c) a polypeptide which comprises the amino acid of SEQ ID NO:4;    (d) a polypeptide which is the polypeptide of SEQ ID NO:4; or    (e) a polypeptide which is encoded by a polynucleotide comprising the sequence contained in SEQ ID NO:3.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.